Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-23
1997-02-25
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514361, 514364, 514382, 514394, A61K 3141
Patent
active
056059191
ABSTRACT:
An angiotensin II antagonist compound is administered to mammals with viral disease. This administration ameliorates virus-associated cell injuries, producing therapeutic effects in viral diseases. This compound is also useful for the prevention of such diseases.
REFERENCES:
patent: 4216313 (1980-08-01), Paget et al.
patent: 4420479 (1983-12-01), Morwick et al.
patent: 4818761 (1989-04-01), Sato et al.
patent: 4956351 (1990-09-01), Mesens et al.
patent: 5294720 (1994-03-01), Jadhav et al.
patent: 5310740 (1994-05-01), Rosenberg et al.
patent: 5360795 (1994-11-01), Townsend et al.
J. Tanaka et al., "Effect of angiotensin II receptor antagonist drug (TCV-116) in viral myocarditis", Japanese Circulation Journal, vol. 57, Supplement 1, p. 119, Item 468, published Mar. 1, 1993.
Supplement to the Journal of the American College of Cardiology vol. 21, No. 2, p. 197A (1993).
A. Matsumori, HERZ, vol. 17, No. 2, pp. 107-111 (1992).
Rezkalla et al., Circulation, vol. 81, No. 3, pp. 1039-1046 (1990).
Kumar Shailendra
Takeda Chemical Industries Ltd.
LandOfFree
Treatment for viral diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for viral diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for viral diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974271